Related Party Transactions |
9 Months Ended |
|---|---|
Sep. 30, 2026 | |
| Related Party Transactions [Abstract] | |
| Related Party Transactions | 11. RELATED PARTY TRANSACTIONS The Company had the following related party transactions: •
Pursuant to the terms of various contract research service agreements with Shin Nippon Biomedical Laboratories Ltd., a contract research organization and one of the Company’s stockholders, and its affiliates (together, “SNBL”), the Company paid SNBL $0.7 million and $5.5 million, respectively, during the three and nine months ended September 30, 2026. The Company paid SNBL $0.6 million during the three and nine months ended September 30, 2025. Through September 30, 2026, the Company has paid an aggregate of $8.9 million to SNBL for the aforementioned various service agreements. During the three and nine months ended September 30, 2026, the Company incurred expenses of approximately $0.9 million and $3.1 million, respectively, related to the aforementioned various service agreements. During the three and nine months ended September 30, 2025, the Company incurred expenses of approximately $1.5 million and $3.1 million, respectively, related to the aforementioned various service agreements. |